RT Journal Article
SR Electronic
T1 State-by-State estimates of R0 at the start of COVID-19 outbreaks in the USA
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.17.20104653
DO 10.1101/2020.05.17.20104653
A1 Ives, Anthony R.
A1 Bozzuto, Claudio
YR 2020
UL http://medrxiv.org/content/early/2020/05/22/2020.05.17.20104653.1.abstract
AB We estimated the initial rate of spread (r0) and basic reproduction number (R0) for States in the USA experiencing COVID-19 epidemics by analyzing death data time series using a time-varying autoregressive state-space model. The initial spread varied greatly among States, with the highest r0 = 0.31 [0.23, 0.39] (95% CI) in New York State, corresponding to R0 = 6.4 [4.3, 9.0] (95% CI). The variation in initial R0 was strongly correlated with the peak daily death count among States, showing that the initial R0 anticipates subsequent challenges in controlling epidemics. Furthermore, the variation in initial R0 implies different needs for public health measures. Finally, the States that relaxed public health measures early were not those with the lowest risks of resurgence, highlighting the need for science to guide public health policies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementPartial funding for this work was provided by the National Science Foundation of the USA.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll code and data are provided in the Supporting Information. The data are from: The New York Times (2020) Coronavirus (Covid-19) data in the United States. https://github.com/nytimes/covid-19-data